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Background. Legionnaires’ Disease (LD) is a mild to severe, potentially lethal, 
respiratory syndrome caused by members of the Legionella genus, in particular 
L. pneumophila serogroup (sg) 1 alone causes about 95% of culture confirmed 
cases. The infection is usually acquired by inhalation of aerosols originating 
from contaminated fresh water sources, consequently typing of both clinical and 
environmental isolates is crucial to rapidly identify the possible source and 
prevent further cases. Legionellae are difficult to isolate by culture, moreover as 
respiratory samples are not available for up to 65% patients, alternative 
techniques are needed to diagnose LD and maximise the amount of typing data 
that can be obtained to aid investigations. Urinary antigen detection and 
serology provide very limited information regarding the infecting strain, while the 
advent of PCR and Sanger sequencing has allowed reliable diagnostic and 
typing methods to be introduced.  
 
Objectives. The aim of this study was to improve existing diagnostic and typing 
molecular assays, and to develop new ones to further standardise diagnostic 
and typing procedures across members of the European Society for Clinical 
Microbiology and Infectious Diseases (ESCMID) Study Group for Legionella 
Infections (ESGLI). Utility of the assays was assessed in both routine and 
outbreak scenarios. 
 
Methods.  A wide range of both in silico and in vitro experiments were used to 
design and validate specific oligonucleotides to improve detection and typing of 
L. pneumophila. Genomic DNA was manually extracted and prepared for Whole 
Genome Sequencing (WGS) using Illumina platforms. A bioinformatic approach 
was used to design a WGS based typing scheme and decipher the evolution of 
L. pneumophila sg1 Sequence Type (ST) 47, a major disease-causing strain.  
 
Results. A real-time PCR detecting L. pneumophila and sg1 specific targets was 
validated with international colleagues and made available to ESGLI members. 
Sequence based typing was improved and expanded, and specific typing 
guidelines produced. A 50 gene core-genome MLST was identified as the best 
approach to improve the current typing method. ST47 was shown to be a 
‘chimera’ between ST109 and ST62, and a specific real-time PCR was 
designed to detect this strain. 
 
Conclusions. The results of this study allowed researchers to obtain faster and 
more accurate diagnosis of LD, and L. pneumophila typing data from both 
isolates and primary samples. A metagenomics approach is presently under 
evaluation to obtain typing results by WGS directly from clinical and 
environmental samples.  
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The Legionella genus comprises Gram-negative bacteria widespread in both 
natural (e.g., streams, lakes, rivers, natural spas, water in hydrothermal areas, 
and sub-terrestrial groundwater sediments) and man-made (e.g., air-
conditioning systems, potable water supplies, ornamental fountains, and 
plumbing fixtures and fittings in hospitals, shops and homes) freshwater 
habitats. Legionella strains have also been recovered from moist potting soils, 
mud, riverbanks, and rainwater run-off (Harrison, 2005). Legionellae can live as 
free-cells or infect and multiply within protozoan hosts such as Acanthamoeba, 
Hartmanella, Naegleria, Valkampfia, Echinamoeba, Tetrahymena and 
Cyclidium.  Occasionally, they can also infect humans causing either a mild to 
severe form of pneumonia known as Legionnaires’ disease (LD) or a ‘flu-like 
syndrome known as Pontiac Fever. Man-made environments are the source in 
almost all cases, thus regular maintenance and appropriate disinfection 
measures are essential to prevent LD (Harrison, 2005). 
 
LD can manifest both as sporadic cases and explosive outbreaks. The last 
reported UK incidence was 5.2 cases per million inhabitants (331 total cases), 
compared to an average of 11.4 (0.1 - 37.4) in Europe (ECDC, 2015). Usually 
patients require antibiotic treatment and hospitalisation, often in an intensive 
care unit, with the most critical cases needing extra-corporeal membrane 
oxygenation. The infection is typically acquired by inhalation of aerosols 
originated from colonised water systems (Phin et al., 2014). So far person-to-
person transmission has only been demonstrated in one instance involving two 
fatal cases in Portugal (Correia et al., 2016). After the first documented incident 
involving 182 patients with 29 fatalities that occurred in 1976 during the 58th 
annual meeting of the American Legion (Philadelphia, USA), many other 
outbreaks have been identified worldwide (Phin et al., 2014). LD is also a well-
recognised nosocomial infection characterised by an increased mortality rate 
with respect to community acquired cases (ca. 30% vs 10%) due to the 
weakened immune response of the infected patients (Phin et al., 2014). Often, 
LD is acquired during travel, consequently robust and reproducible typing 
methods are necessary to compare results obtained on strains isolated in 




Out of 59 different species included in the Legionella genus 
(www.bacterio.net/legionella.html), Legionella pneumophila serogroup (sg) 1 
strains are responsible for ca. 85% of culture confirmed LD cases in Europe 
(ECDC, 2015).  Indeed, these strains are also the leading cause of LD 
outbreaks: to date only one documented outbreak has been shown to be 
caused by a non-sg1 strain of L. pneumophila (Sedgwick et al., 2007). 
Diagnostic methods were originally designed to target sg1 strains (the first to be 
isolated from patients), thus they often lack sensitivity for other strains and 
species belonging to the Legionella genus. The role of such strains in the 
epidemiology of LD infections is consequently underestimated.  
 
As first line antibiotics such as -lactams are not effective against an 
intracellular pathogen such as Legionella, prompt and accurate diagnosis is 
crucial to provide patients with an appropriate treatment, i.e., macrolides 
(usually azithromycin) and/or fluoroquinolones (usually levofloxacin) (Pedro-
Botet and Yu, 2006). Clinical manifestation and examination by chest X-ray do 
not allow physicians to clearly differentiate LD from other forms of pneumonia, 
hence targeted laboratory tests are necessary to obtain a correct diagnosis.  
 
After the Philadelphia outbreak, culture and serology were the only laboratory 
methods available to diagnose LD. Legionellae require L-cysteine and iron salts 
to grow, consequently they are not isolated unless dedicated media such as 
Buffered Charcoal Yeast Extract (BCYE) are used (Harrison, 2005). Typically 
three to seven days are required to obtain Legionella colonies (with negative 
culture results issued only after 10 days of incubation) and Legionella strains 
are often overgrown by faster growing microorganisms such as Candida spp. 
and/or Pseudomonas aeruginosa. Serology requires serum samples to be 
collected >14 days after onset of symptoms, which may serve as a useful 
retrospective, but not primary diagnostic method. In the early 1980s, 
commercial kits for the detection of L. pneumophila antigen in urine started to 
become available, and whilst they proved valuable in making a prompt 
diagnosis of LD, they are most reliable only when sg1 strains are involved and 
they provide no typing data to aid outbreak investigation. Nevertheless, with up 
to 65% of LD patients failing to produce sputum (von Baum et al., 2008), having 
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instead a so-called “dry cough”, detection of L. pneumophila sg1 antigen in 
urine still remains the main diagnostic method for LD. After the advent of PCR 
in the mid-late 1980s, infectious diseases were promptly and specifically 
diagnosed prior the isolation of the causative agent in culture or when 
organisms could not be isolated. It became then possible to quickly and reliably 
diagnose LD cases caused by Legionella strains other than L. pneumophila sg1 
and to later design typing methods for L. pneumophila based on DNA sequence 
analysis.  
 
Definitive typing of Legionella pneumophila is essential to support or refute an 
epidemiology link between clinical and environmental isolates; this can play a 
pivotal role in the decision to launch further environmental investigations in 
order to determine the possible infection source with the aim of preventing 
further cases. Typing using monoclonal antibodies (mAb) was one of the first 
phenotypic methods to be introduced (Helbig et al., 2002), but it offers limited 
discriminatory power only for L. pneumophila sg1 strains. This approach splits 
sg1 isolates into mAb 3/1 positive (i.e., Philadelphia, Allentown, France, 
Knoxville and Benidorm subgroups) that are likely to cause community acquired 
cases and outbreaks, while mAb 3/1negative strains (i.e. Oxford, OLDA, 
Bellingham, Camperdown and Heysham subgroups) are usually related to 
hospital acquired cases and are found in  immunocompromised patients. 
Presently Sequence-Based Typing (SBT) is the gold standard for typing of L. 
pneumophila isolates and the pillar of LD outbreak investigation (Gaia et al., 
2005; Ratzow et al., 2007). Briefly, the method is a modification of the Multi-
Locus Sequence Typing, MLST (Maiden et al., 1998) principle where 4 of the 7 
targets (namely, flaA, pilE, asd, mip, mompS, proA and neuA) are not 
housekeeping genes, hence the SBT name instead of MLST.  The seven 
targets are amplified by PCR using specific sets of primers and PCR products 
are sequenced using the Sanger method. Tracefiles are then analysed using a 
specific Sequence Quality Tool (SQT) available online on the L. pneumophila 
SBT database  (www.hpa-bioinformatics.org.uk/cgi-
bin/legionella/sbt/seq_assemble_legionella1.cgi): consensus sequences 
obtained from forward and reverse primers are trimmed and compared to 
previously assigned allele numbers and then set into the above pre-determined 
order to generate a 7-digit allelic profile (e.g. 1,4,3,1,1,1,1) and a Sequence 
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Type (ST) represented by a number (e.g., ST1). The database of L. 
pneumophila Sequence Types (STs) is hosted by Public Health England (PHE) 
and contains data submitted by colleagues from worldwide locations. As of 15 
July 2016, it holds 10,908 entries comprising 2191 STs from 61 countries 
(bioinformatics.phe.org.uk/legionella/legionella_sbt/php/sbt_homepage.php). A 
nested modification (nSBT) increasing the sensitivity of the SBT method is also 
available to obtain typing data directly from those primary samples where L. 
pneumophila DNA was detected but the organism was not isolated by culture 
(Ginevra et al., 2008; Mentasti and Fry, 2012). SBT and nSBT have been 
extensively and successfully used to analyse both LD clusters and outbreaks, 
however in some instances full allelic profiles cannot be obtained (and 
consequently a ST cannot be designated), due to strains carrying mutations in 
the primer binding sites that prevent the amplification of one or more targets, or 
presence of insufficient target DNA. Also, as common sequence types such as 
ST1, ST23, ST37, ST42, ST47 and ST62 cause ca. 50% of LD cases, some 
investigations remain unresolved (David et al., 2016). 
 
The main aim of this study was to improve laboratory methods for analysing 
samples related to LD cases by designing, validating and implementing state of 
the art molecular techniques able to rapidly and effectively detect and type L. 
pneumophila. The ability and utility of these techniques to rapidly identify and 
tackle possible LD outbreaks was assessed.  
 
 
Development of L. pneumophila 3plex qPCR by the European Society of 
Clinical Microbiology and Infectious Diseases Study Group for Legionella 
Infections  
 
Although PCR has proven decisive in making diagnosis of many infectious 
diseases, detection of L. pneumophila DNA by this method is still not considered 
by the European Centre for Disease Control (ECDC) as proven evidence of LD 
(http://ecdc.europa.eu/en/healthtopics/legionnaires_disease/surveillance/Pages/E
U-case-definition.aspx), due to lack of reliable, internationally standardised 
methods. Following the formation of the European Society of Clinical Microbiology 
and Infectious Diseases (ESCMID) Study Group for Legionella Infections (ESGLI) 
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in 2012, the design and validation of a specific real-time PCR was identified as a 
priority to standardise molecular diagnosis of L. pneumophila infections across 
Europe and then approach the ECDC to consider L. pneumophila PCR positive 
patients as proven cases.  
 
A survey of ESGLI laboratories in November 2012 identified ABI 7500 
(ThermoFisher Scientific), LightCycler 480II (Roche) and RotorGene-Q (Qiagen) 
as the three real-time PCR platforms mostly used by members (23 out of 30), and 
it was subsequently decided to validate an in-house assay detecting both L. 
pneumophila and sg1 markers that could be widely and easily implemented 
across Europe. The National Reference Laboratory at PHE Colindale was given 
the task to develop the assay. A subgroup comprising members of five countries 
was formed, led and coordinated by the PhD candidate. 
   
A qPCR method targeting the macrophage infectivity potentiator gene (mip) of L. 
pneumophila was already routinely used at PHE Colindale on the LightCycler 2.0 
(Roche) since 2008 (Mentasti et al., 2012), however this method was based on 
dual hybridisation probes which are less commonly used than other types, such 
as hydrolysis probes, due to the fact that they are less readily available, more 
complicated to design and more expensive; furthermore, the LightCycler 2.0 only 
allows simultaneous detection of two targets, thus limiting the options for inclusion 
of multiple targets and an internal control. In 2011, French colleagues at the 
National Legionella Reference Laboratory (Lyon) and the Pasteur Institute (Paris), 
used a bioinformatic approach to identify the O-antigen ABC transporter 
permease (wzm) as the molecular marker for sg1 strains of L. pneumophila. 
Subsequently they designed and validated a real-time PCR using hydrolysis 
probes to reliably detect such strains (Mérault et al., 2011). It was therefore 
decided to adopt a rational approach to design a new mip assay based on 
hydrolysis probes and to combine this with the wzm assay. An internal control 
assay targeting the green fluorescent protein gene (gfp) (Murphy et al., 2007) was 
also added to check for inhibition where mip and wzm amplification were negative.  
 
A 402 bp fragment internal to the mip gene is the fourth target of the L. 
pneumophila SBT protocol, consequently sequence data for this fragment are 
available for all the strains present in the L. pneumophila SBT database; 9423 
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sequences for a total of 59 mip alleles were available at the beginning of the study 
(October, 2012) and had risen to 74 by the end of it (February, 2015). Allele 
sequences were downloaded from the database and aligned using ClustalW 
(http://www.ebi.ac.uk/Tools/msa/clustalw2). Oligonucleotides were designed using 
Primer3 (http://primer3plus.com/web_3.0.0/primer3web_input.htm) in conserved 
regions allowing a maximum of one mismatch in either the primer or probe binding 
sites. A validation protocol following criteria published by Saunders et al. (2013) 
was written by PHE Colindale and distributed to ESGLI colleagues to perform a 
multicentre validation.  A large panel of reference strains (251), external quality 
assessment (EQA) samples (100) and clinical samples (132) was included to 
complete the validation. A full validation report was later published (Mentasti et 
al., 2015) under the auspices of ESGLI and a detailed protocol for each of the 
three platforms was made available to ESGLI members with the intent to 
promote the use of this assay. 
 
The L. pneumophila 3plex qPCR has been routinely used by PHE Colindale to 
diagnose and confirm LD cases since 2013.  This method has proven effective 
and specific in outbreak scenarios where rapid detection and differentiation of L. 
pneumophila sg1 DNA from both clinical and environmental samples is 
imperative to provide timely results to the Incident Management Team (IMT). 
Since 2012, this method has been used in at least seven instances where 
urgent results were specifically requested by the IMT to aid their actions. In all 
cases the assay proved reliable and informative (Mentasti et al., 2016). 
 
 
Improvement of the SBT protocol 
 
As LD is often travel-associated (i.e., clinical and environmental strains isolated 
in different countries), when typing L. pneumophila, reproducible and 
comparable results must be obtained. As the ECDC official collaborating centre 
for legionellosis from 1998 to 2013, PHE Colindale standardised the L. 
pneumophila SBT method among Legionella National Reference Laboratories 
in Europe (and beyond) by providing training and guidelines (Mentasti and Fry, 
2012) based on previously published papers, and improving them with ad hoc 
experiments. Primer sequences were modified to obtain improved sequencing 
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results. Primers were re-designed to bind SBT targets externally to the originally 
published primers to improve the sequencing results at beginning and end of 
the target, and obtain fully double-stranded sequences. M13 forward (5' - 
GCGTATTGCTCAAAATACTG - 3') and M13 reverse (5' - 
GGTATCACCTGCGGTTCCA - 3') tags were attached to the amplification 
primers so that fewer primers were required when sequencing the 7 PCR 
products (Mentasti et al., 2012). SBT results of Legionella reference 
laboratories in Europe and beyond were analysed yearly using a L. 
pneumophila SBT EQA scheme run by PHE under the auspices of ECDC. A 
total of 10 SBT EQA panels were distributed between 2003 and 2014 with 
participants raising from 16 to 38. A brief summary of results in detailed in Table 
1.  
 
After the SBT scheme was completed, it became evident that the amplification 
of neuA, the seventh SBT target was not possible in some strains of L. 
pneumophila, consequently a full 7-allele profile could not be obtained or a 
Sequence Type designated. This issue had already been described for other 
pathogens such as Haemophilus influenzae where the deletion of an operon 
encoding a fuculokinase, which is part of the seven-locus sequence typing 
scheme (Riddenberg et al., 2010), caused some strains to be untypable. A 
study in collaboration with the German Legionella Reference laboratory in 
Dresden (Farhat et al., 2011) showed that in those L. pneumophila strains a 
variant (designated neuAh) with about 70% sequence homology to neuA is 
present, thus neuA primers are not able to bind it and the target is not amplified. 
New primers (neuA_up and neuA_do2) were designed with the same binding 
sites of the original primers to amplify both neuA and neuAh, however due to 
sequence variation, they contained several ambiguities, the resulting 
sequencing results were of suboptimal quality and did not pass the strict criteria 
of the L. pneumophila SQT.  New primers (neuAh_L and neuAh_R) were later 
designed to specifically amplify and sequence neuAh with QV20+ results (i.e., 
the total number of bases in the entire trace that have basecaller quality value 
of ≥20) of ca. 800 when neuAh_L and neuAh_R were used, whilst values of ca. 
400 and 250, respectively were obtained, when neuA_up and neuA_do2 were 
used. Considering that 354 bp is the length of the fragment used to determine 
the allele type for the neuAh target, a QV20+ result of ca. 250 for the reverse 
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sequence is well below what is necessary to obtain a good quality double-
stranded consensus sequence across the entire allelic region. The new neuAh 
primer sequences were distributed to all international laboratories taking part in 
the L. pneumophila SBT EQA. Results obtained worldwide on a panel of five 
selected strains showed that the new primers were reliable in both amplifying 
and characterising the neuAh target. Design and international validation of 
these primers together with a full characterisation of the neuAh target were later 
published (Mentasti et al., 2013). A legionella outbreak caused by one such 
strain occurred in 2005 on a cruise ship in northern Europe. As part of the 
validation of the new primers it was possible to retrospectively complete the 7 
allele profile of the infecting strain which was characterised as L. pneumophila 
sg5 ST1327 (11,14,16,31,15,13,210). Legionella Reference laboratories 
worldwide adopted the neuAh primers and where possible completed the allelic 
profile of those L. pneumophila strains previously uploaded to the SBT 
database without the seventh target. This allowed the database curators to later 
assign an ST number to them. By mid-2013 of the about 1600 or so extant STs, 
100 (about 6%) had been allocated thanks to the fact that the neuA/neuAh 
issue was resolved. A total of 29 neuAh alleles distributed in 224 different STs 
(478 entries), has been so far submitted to the SBT database (accessed on 
15/07/2016). 
 
The above SBT modifications and guidelines were adopted to investigate the 
molecular epidemiology of L. pneumophila in Israel and published in 
collaboration with colleagues at Jerusalem University Hospital and Israeli 
Ministry of Health (Moran-Gilad et al., 2014). This study was the first of its kind 
published from a Middle Eastern country. Results showed many similarities to 
the epidemiological trends found in European countries, especially in relation to 
incidence, seasonality and methods used for laboratory diagnosis. Differences 
were also seen, including a larger proportion of nosocomial cases than that 
reported in many countries. Other unusual features included a surprisingly high 
percentage (i.e., 43%) of L. pneumophila sg1 ‘OLDA/Oxford’ ST1 (1,4,3,1,1,1,1) 
strains compared to other counties (e.g., 4.8% in the UK) resulting in reduced 
clinical strain diversity; a notable number of clinical cases involving L. 
pneumophila sg1 ‘Allentown/France ST40 (3,6,1,14,14,9,11) and the presence 
of the rare L. pneumophila sg3 ST338 (2,10,15,28,9,4,13) strain among 
13 
 
environmental isolates. A substantial percentage of typed strains yielded novel 
STs which were added to the L. pneumophila SBT database. 
 
A fatal LD case in an Israeli infant was also analysed with the above protocols 
and published in in collaboration with Israeli Public Health colleagues (Moran-
Gilad et al., 2012). Although this was not the first described case of LD in an 
infant (Unit for Surveillance and Control of Communicable Diseases, 2009) it 
was the first to fully characterise a clinical and epidemiologically linked 
environmental strain (L. pneumophila sg1 Oxford/Olda ST1) in a paediatric LD 
case, and to demonstrate humidifiers (filled with non-sterile tap water) as a 
source of LD. Further to these results, the Israeli Public Health Authorities 
approached the Standards Institution of Israel to set up new regulations 
mandating hazard labelling of cold water humidifiers and package inserts were 
included in user manuals with the aim to prevent further LD cases associated 
with the use of tap water in humidifiers. 
 
 
Rapid investigation of LD 
 
Using traditional culture methods, at least six days are necessary to isolate and 
fully type L. pneumophila strains. In some cases L. pneumophila cannot be 
isolated due to overgrowth of contaminant flora or due to the use of appropriate 
antibiotic therapy (clinical sample) or disinfectant (environmental samples) prior 
to specimen collection. Whilst these limitations might be tolerated for sporadic 
LD cases bearing little risk to the wider population, when a possible outbreak is 
suspected the use of rapid molecular tests could be decisive in identifying the 
possible source and so enabling prompt public health measures to prevent 
more LD cases from occurring.  
 
In preparation for the 2012 Olympics held in London (UK), legionella together 
with gastrointestinal pathogens and ‘flu were declared as a top public health 
threats. PHE Colindale was requested to devise a rapid response strategy 
(RRS) should an LD outbreak have occurred during the Olympics. The adopted 
approach was the rapid detection of L. pneumophila and sg1 DNA on both 
clinical and environmental samples by using the ESGLI 3plex PCR (Mentasti et 
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al., 2015) followed by nested SBT (Ginevra et al., 2009; Mentasti and Fry, 2012) 
applied to DNA extracts PCR-positive for L. pneumophila DNA. The efficacy 
and reliability of molecular methods in detecting and typing L. pneumophila was 
previously retrospectively demonstrated (Mentasti et al., 2012). Briefly, in a total 
of 227 respiratory samples obtained from legionella urinary antigen positive 
patients, L. pneumophila was successfully cultured from 147 (64.8%), while L. 
pneumophila DNA was detected from 194 (85.5%); moreover, partial to full 
typing results were obtained on 43/47 (91%) PCR-positive culture-negative 
samples. Increased/improved typing results can be obtained retrospectively on 
DNA extracts following culture-negative results, indeed such results could 
instead be rapidly obtained (if required) while waiting for culture results. 
 
The RRS was first used to investigate an outbreak that occurred in Stoke-on-
Trent (Coetzee et al., 2012) in summer 2012. The initial typing results, obtained 
in just 17.5 hours (samples received at 17:00 on 24th July and results reported 
to the IMT at 10:30 on 25th July), were sufficient to identify the LD cluster as a 
definite point-source outbreak. Where L. pneumophila was cultured from clinical 
samples the preliminary results were all confirmed and the infecting strain 
characterised as L. pneumophila sg1 ‘Benidorm’ ST1268 (2,9,2,5,3,17,15). PCR 
screening of environmental samples, identified three specimens positive for L. 
pneumophila and sg1 DNA. Nested SBT yielded a high-quality unambiguous 
ST1268 profile in a swab from a hot tub present in retail premises, whilst partial 
profiles, namely 0,0,0,15,18,1,6 and 8,0,0,15,18,1,6, consistent with ST62 
(8,10,3,15,18,1,6) were obtained from water concentrates collected from cooling 
towers located in industrial premises. The hot tub was identified as the outbreak 
source, however it was not possible to isolate L. pneumophila from the swab 
sample due to high counts of Pseudomonas aeruginosa. Legionella 
pneumophila sg1 ‘Allentown/France’ ST62 was instead isolated from the water 
concentrates. Significantly, ST62 is the fourth main cause of LD cases, however 
due to the availability of these rapid typing results the Health and Safety 
Executive visited the premises where the cooling towers were located and 
implemented urgent disinfection measures. No cases due to ST62 strains were 




Due to the success during the Stoke-on-Trent investigation, the RRS has since 
been used by PHE Colindale to investigate urgent LD cases and possible 
outbreaks. So far it has rapidly delivered crucial epidemiological data in seven 
significant LD incidents: initial typing results were available in 1.58 day (SD 
1.01) while results were obtained in 9.53 (SD 3.73) days when standard culture 
and typing protocols were used (Mentasti et al., 2016). 
 
Rapid detection and evolution of ST47 
For reasons yet to be understood, L. pneumophila sg1 ST47 (5,10,22,15,6,2,6) 
is the leading cause of LD in Belgium (Vekens et al., 2012), England & Wales 
(Harrison et al., 2009), France (Ginevra et al., 2008) and The Netherlands (Den 
Boer et al., 2008). Despite more than 2000 different L. pneumophila STs 
present in the SBT database, ST47 alone causes more than 20-25% of 
community acquired LD cases, but it is rarely isolated from the environment 
when investigations following LD incidents are carried out. 
With the aim of designing a specific test to improve detection of ST47 in the 
environment and tracing the evolution of ST47, the genome of a total of 129 
ST47 isolates was sequenced and analysed in collaboration with colleagues at 
the Wellcome Trust Sanger Institute (Cambridge, UK), the French Legionella 
Reference Laboratory in Lyon (France) and the Pasteur Institute (Paris, 
France). WGS analysis revealed that the ST47 genomes (3.47Mb) contain a 
plasmid of about 150kb, interestingly no recombination was found and a 
maximum of 33 SNPs were identified between any pair of strains. Comparison 
of these genomes to that of the 32 STs representative of the main L. 
pneumophila clades (Underwood et al., 2013), revealed 64 possible ST47 
specific Open Reading Frames (ORFs). Among these, the ones present in the 
ST47 plasmid and the ones that generated positive hits when compared using 
BLASTN against the NCBI database where excluded. Primers were designed to 
amplify fragments from the remaining 21 ORFs, analysed by BLASTN against 
the NCBI database and then tested on a subset of reference, clinical and 
environmental strains present in the collections of the Legionella reference 
laboratories of England & Wales and France. LPO_1073 was identified as the 
target with highest specificity. PFAM (http://pfam.xfam.org) was not able to 
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assign the translated sequence to any so far described protein family and the 
only positive match on the NCBI database is the “Lorraine” strain of L. 
pneumophila, which is the reference ST47 strain. A hydrolysis probe was 
designed and added to the primers to set up and validate a real time PCR 
assay. Interestingly, the only positive results apart from ST47 isolates, were 11 
ST109 (5,1,22,15,6,10,6) isolates from France, while 8 ST109 isolates from 
England & Wales gave no reaction. When the remaining 25 ST109 isolates 
present on the L. pneumophila SBT database were tested, 26 isolates in total 
(out of 44) resulted in positive results. WGS analysis revealed that “France” 
ST109 had acquired a 16,266 bp mobile element, probably a phage, (absent in 
the genome of “England & Wales” ST109) carrying LPO_1073. When 
sequenced genomes of closely related STs, namely ST74 (5,1,22,30,6,10,6) 
and ST82 (5,1,22,10,6,10,6) were added to the WGS analysis, it became 
evident that a gradual acquisition by homologous recombination of two large 
fragments, 170,636 bp and 9,326 bp respectively, of the ST62 genome led to 
the formation of ST47 (Fig. 1) indicating that these strains shared a common 
niche allowing recombination to occur. Significantly, only 44 ST109 isolates are 
present in the SBT database in contrast to 612 ST47 isolates: the acquisition by 
“France” ST109 of a large portion (13.5 %) of ST62 genome, a well-known 
cause of LD, undoubtedly generated a strain with increased ability to cause 
disease with respect to its ancestor. Analysis of the recombined regions 
revealed that they contain core genes (including 4 of the 7 SBT targets) thus a 
clear explanation of this increased incidence was not found (Mentasti et al., 
submitted). 
 
PHE “firepower” against LD 
A major aim of the PHE Legionella reference laboratory is to generate typing 
data to help describe the epidemiology of LD in England & Wales, and to rapidly 
respond to clusters of LD cases to determine whether a point-source outbreak 
is possibly occurring. Environmental investigations are then triggered when 
required to identify the infection source and prevent further cases.  
The LPO_1073 real-time PCR was added to the rapid LD investigation 
approach using L. pneumophila 3plex PCR and direct nSBT. The added value 
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of this assay derives from data gathered from LD epidemiology: as ST47 is the 
leading cause of sporadic LD, molecular detection of ST47 when investigating 
clusters can be informative of increased LD incidence and exclude outbreaks.  
The RRS plus LPO_1073 PCR was used for the first time to rapidly investigate 
a cluster of 4 LD cases that occurred during the same week in the summer of 
2013 in South Wales. As LD is a relatively uncommon type of infection, 
identification of four cases in a short period of time in patients with a possible 
epidemiological link was highly indicative of a point-source outbreak, 
consequently the PHE full molecular approach was deployed (Table 2). The 
same day (Day 0) that respiratory specimens were received, L. pneumophila 
sg1 DNA was detected by qPCR in all 4 patients and 2 were also positive with 
the LPO_1073 assay. This result indicated that a point-source outbreak was 
highly unlikely as patients were likely to have been infected by different strains 
of L. pneumophila sg1.  Direct nested SBT results were available on Day 1 and 
showed the 2 LPO_1073 PCR positive patients respectively were infected by an 
ST47 strain and by a strain with a partial allelic profile (5,0,22,15,6,2,6) 
consistent with ST47. The other two patients were infected by strains with allelic 
profiles distinct from each other and from ST47. Legionella pneumophila was 
isolated from 3 of the 4 patients and SBT results available on Day 8 confirmed 
the LPO_1073 and direct nSBT preliminary results (Table 2). 
 
Whole Genome Sequencing (WGS) typing approach 
Despite SBT being the current gold-standard for typing of L. pneumophila, a few 
STs cause the majority of infections, consequently some investigations remain 
unresolved. Furthermore, some strains carry mutations in the SBT primer 
binding sites; thus they cannot be fully typed. 
The development of Next Generation Sequencing (NGS) platforms has 
progressively improved access to Whole Genome Sequencing (WGS) and 
allowed a wider use of this technique. The application of four WGS-based 
approaches, namely Single Nucleotide polymorphism (SNP) analysis, extended 
Multi-Locus Sequence Typing (MLST), gene presence/absence and a Kmer-
based method comparing the kmer content (18-mers) between all de novo 
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assemblies in order to determine their similarity to each other 
(https://github.com/phe-bioinformatics/kmerid), was evaluated for the 
epidemiological typing of L. pneumophila using criteria published by the 
ESCMID Study Group for Epidemiological Markers (ESGEM) (Van Belkum et 
al., 2007) and compared to results obtained by SBT. Briefly, the criteria are 
based on the assessment of typability (proportion of isolates that can be 
assigned to a type using a particular method), reproducibility (proportion of pairs 
of sequencing replicates assigned to the same type), epidemiological 
concordance (proportion of epidemiologically related set of isolates assigned to 
the same type), discriminatory power (proportion of epidemiologically unrelated 
set of isolates assigned to different types) and stability (ability to assign a 
particular strain to a same type after different culture procedures and 
conditions). 
Paired-end libraries were prepared on DNA samples extracted at PHE, while 
sequencing was performed with Illumina HiSeq at Wellcome Trust Sanger 
Institute (UK) on paired-end reads of 100 bases. Where a closely related 
genome (KmerID > 90%) was already available, genomes were assembled 
using an in-house mapping pipeline, otherwise de novo assembly was applied 
(David et al., 2016).  
In a total of 370 genomes (45 distinct STs), all methods produced a higher 
index of discrimination (from D = 0.972 using ribosomal MLST to D = 0.999 
using SNP analysis) with respect to SBT (D = 0.940). All methods were able to 
differentiate epidemiologically unrelated isolates of the same ST into further 
types, while SNP analysis separated almost all isolates into different types. 
Highly discriminatory methods (such as SNP analysis) produce poor 
epidemiological concordance, generating virtually a different type for each 
analysed isolate. The best compromise was identified in a core genome (cg) 
MLST approach using 50 genes (D = 0.991): this method has a lower 
discriminatory power than SNP analysis but maintains good epidemiological 
concordance.  
Unfortunately, the short reads on which Illumina technology is based produce 
results that do not allow result compatibility with SBT: mompS, the fifth SBT 
target, is present in multiple copies (usually two) in the genome of L. 
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pneumophila. In those strains where the mompS copies are not identical, the 
allele type of the SBT copy cannot be determined by Illumina WGS analysis, 
consequently Sanger sequencing will still be necessary in some instances. NGS 
platforms generating longer reads (e.g. PacBio or MinION) are available, 
however they do not allow high-throughput analysis, thus costs are much higher 
and not suitable for routine use in a public health environment. 
A WGS working group was established within ESGLI during the meeting held in 
London in September 2015 and is presently discussing the results of this 





As discussed, direct nSBT is presently the fastest way to obtain typing results 
when investigating outbreaks, however the level of data that can be obtained is 
limited to the seven SBT targets. Hence, no more than a ST (if full allele profiles 
are obtained) can be resolved. Studies are presently addressed at exploiting the 
full potential of WGS using metagenomics; this approach applies a suite of 
genomic technologies and bioinformatics tools to directly access the genetic 
content of entire communities of (micro-)organisms without the need for 
cultivation.  
PHE and Imperial College have recently set up a collaborative study to design 
and validate a metagenomics protocol to be used during LD outbreak 
investigations. WGS would be applied directly to DNA extracted from clinical 
samples to allow scientists to obtain a greater amount of data about the 
infecting strain than just the ST, with the aim of promptly identifying strain-
specific PCR target(s) and designing specific primers. Environmental 
specimens could be then screened for presence of the specific target(s) by 
SYBR-green real-time PCR to quickly identify the infection source and apply 
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Figure 1. Circular representation of “Lorraine” ST47 genome and comparison to 
the genome of closely related strains (i.e., ST74, ST82, “England & Wales” 















Table 1. Summary of SBT EQA results 
 
Distribution 1 2 3 4 5 6 7 8 9 10 
Year 2003 2004 2006 2007 2008 2010 2010 2011 2012 2014 
Participant 16 16 28 23 32 38 38 37 37 37 
Expected  
Results 













Table 2. Summary of results obtained during investigation of LD cluster occurred in South Wales in 2013.  
 
Location Sample 
PCR Nested SBT L. pneumophila sg1 SBT 
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Appendix IV: guidelines 
 
 
